Use access key #2 to skip to page content.
$22.05 0.92 (4.35%)
11/21/2008 4:00 PM

CONMED Corp (CNMD)

CAPS Rating:
*

A medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating CNMD

Add Stock to Watchlist

What the Community Thinks

CONMED Corp At A Glance

Current Price: $22.05
Last Trade Time: 11/21/2008 4:00 PM
Open: $21.44
Previous Close: $21.13
Daily Range: $20.09 - $22.06
52-Week Range: $21.00 - $34.98
Volume: 660,217
Market Cap: $613.23M
P/E Ratio: 13.37
Compare Our Special Broker Offers!

Stock Trends

CNMD VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for CNMD

More Headlines...

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

Recs

1

CONMED Corp (CNMD)

Avatar vcbthornton (46.39) Submitted: 1/09/07 6:02 PM

This company supplies some of the materials necessary for surgical procedures. It has done well in the past, but it seems to have encountered a lot of competitive pressures recently. Revenues are OK, but earnings are taking a hit. Has a lawsuit outstanding against JNJ, but even if this is resolve...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 3 of 3  

Recs

0

 (CNMD)

Avatar dexion10 (92.56) Submitted: 8/29/08 3:47 PM : Underperform Start Price: $31.97 CNMD Score: -10.07

too much insider selling. early exercise and sell etc.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CNMD)

Avatar burnishedcoppera (< 20) Submitted: 7/14/08 10:05 PM : Outperform Start Price: $27.40 CNMD Score: 18.21

Minimally Invasive, meaning less likely to cut you open, meaning less hospital time and less recovery time.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (CNMD)

Avatar vcbthornton (46.39) Submitted: 1/09/07 6:02 PM : Underperform Start Price: $22.80 CNMD Score: -42.76

This company supplies some of the materials necessary for surgical procedures. It has done well in the past, but it seems to have encountered a lot of competitive pressures recently. Revenues are OK, but earnings are taking a hit. Has a lawsuit outstanding against JNJ, but even if this is resolved in their favor, I think a buyout is the best that could happen.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 3 of 3  

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRichPzena 21.48 09/30/07 Outperform NS $27.99-21.22%-50.30%+29.08 Toggle the visibility of 60-Second Pitch and replies
TrackSoros < 20 09/30/07 Outperform NS $27.99-21.22%-50.30%+29.08 Toggle the visibility of 60-Second Pitch and replies

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links